News from oramed pharmaceuticals inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 08, 2010, 09:18 ET

Oramed Pharmaceuticals to Present at the 9th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2010

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), (http://www.oramed.com), a developer of oral delivery systems, today announced today that it was...

Jun 02, 2010, 09:14 ET

Oramed Pharmaceuticals Forms Joint Venture - Launches Entera Bio Ltd.

Oramed Pharmaceuticals Inc. (OTCBB: ORMP), a developer of oral drug delivery systems, announced today that its subsidiary Oramed Ltd. entered into...

May 26, 2010, 09:19 ET

Oramed Pharmaceuticals Announces Publication of Research Article on its Oral Insulin Capsule ORMD-0801 in Diabetes, Obesity and Metabolism

- Study Data Shows ORMD-0801 Resulted in Glucose and C-Peptide Reduction Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com),...

May 18, 2010, 09:19 ET

Oramed Pharmaceuticals Announces That Dr. Michael Berelowitz, Senior Vice President at Pfizer, Joins its Board of Directors

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) announced that Dr. Michael Berelowitz, MD, joins Oramed Pharmaceuticals' Board of Directors. Dr....

May 06, 2010, 09:10 ET

Oramed Pharmaceuticals Reports Results in Phase 2b Trial of Oral Insulin Administration to Type 2 Diabetes Patients

Oramed Pharmaceuticals Inc. (OTCBB: ORMP), a developer of alternative drug delivery systems, reported today results for the recently completed...

Mar 25, 2010, 13:10 ET

Oramed Announces Completion of Pivotal Phase 2b Clinical Trials of it's Oral Insulin Capsule, ORMD-0801 for Type 2 Diabetes

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) announced today the completion of its' pivotal Phase 2b clinical study of its oral insulin capsule,...

Feb 16, 2010, 09:20 ET

Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D.

- Dr. Amatruda is the Former Senior Vice President and Franchise Head of the Diabetes and Obesity Unit at Merck & Co. Oramed Pharmaceuticals,...

Feb 10, 2010, 09:20 ET

Oramed's Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the Third International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland

Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of alternative drug delivery systems, announced today that its...

Jan 19, 2010, 09:15 ET

Oramed Pharmaceuticals Announces Completion of Patient Enrollment for Pivotal Phase 2B Clinical Trials of ORMD-0801

- Key Trial for Oral Insulin With Expected Results at the End of Q1 of 2010 Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) announced today...

Jan 11, 2010, 13:18 ET

Oramed Pharmaceuticals Announces Filing of Two Registration Statements

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of alternative drug delivery systems, today announced that it has filed two...

Jan 05, 2010, 09:15 ET

Oramed Pharmaceuticals to Present at OneMedPlace Finance Forum in San Francisco, California

Oramed Pharmaceuticals, Inc. (OTC BB: ORMP.OB) (http://www.oramed.com), a developer of alternative drug delivery systems, today announced that the...

Dec 21, 2009, 08:20 ET

Oramed's Dr Roy Eldor was Chosen to Lecture at the First International Conference Held by the Bildirici Center for Diabetes Care Research in Israel.

Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of alternative drug delivery systems, announced today that...

Oct 20, 2009, 09:15 ET

Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Society's Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)

Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB; http://www.oramed.com), a developer of oral drug delivery systems, announced today that its poster...

Sep 09, 2009, 09:15 ET

Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP-1 Analog

Oramed Pharmaceticals, Inc. (OTCBB: ORMP.OB), a developer of oral drug delivery systems, announced today that it has received approval from the...

Sep 03, 2009, 09:15 ET

Oramed Pharmaceuticals to Present at Rodman & Renshaw 11th Annual Healthcare Conference

Oramed Pharmaceuticals Inc. (OTC BB: ORMP.OB) (http://www.oramed.com), a developer of alternative drug delivery systems, announced today...

Aug 25, 2009, 09:15 ET

Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European Oral Drug Delivery Technology Innovation Award

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, today announced that it is the...

Aug 18, 2009, 09:15 ET

Oramed's Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England

Oramed Pharmaceuticals, Inc. (OTC: ORMP) (http://www.oramed.com), a developer of alternative drug delivery systems, announced today that Oramed's...

Aug 04, 2009, 08:45 ET

Oramed Pharmaceuticals was Awarded a NIS 3.1 Million Grant From the Israeli Office of the Chief Scientist

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com), a developer of oral delivery systems, today reported that its wholly owned...

Jul 21, 2009, 07:00 ET

Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients

Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com), a developer of alternative drug delivery systems, today reported positive...

Jun 10, 2009, 07:09 ET

Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009

Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, announced that Oramed was chosen to...